Looking for a Senior Research Associate involved in making of Nanobody® based Pharmaceutical drugs
Ablynx is a biopharmaceutical company dedicated to creating new antibody-based medicines called Nanobodies which will make a real difference to society.
Ablynx has currently over 400 people working on the development of Nanobodies for the treatment of a wide range of diseases, including inflammation, haematology, respiratory disease, immuno-oncology and oncology.
The Analytics group of the CMC Pharmaceutical Development & Technology Department at Ablynx is looking for an experienced Research Associate that will be part of the team responsible for the in depth analysis of the quality and stability of lead Nanobodies® during pre-
clinical and clinical development. A multitude of assays is being used in the team including standard techniques such as Reversed Phase, Size Exclusion and other (U)HPLC chromatography, Mass Spectrometry, UV-
and fluorescence spectroscopy, capillary electrophoresis, Dynamic Light Scattering (DLS), Differential Scanning Calorimetry (DSC), Micro-
Flow Imaging (MFI), Light obscuration, osmolality and viscosity measurements, endotoxin testing, Host Cell Proteins assay, .
Those techniques are applied :
The CV of the applicant should be in English, and include a paragraph specifying the technical expertise.